http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
NantHealth (NH) & NantOmics Announce Study Results Highlighting High Error Rates in Tumor-Only Sequencing for Cancer Treatment in 'Oncotarget' Online Journal
-
NantHealth and NantOmics Announce Publication of Study Highlighting High Error Rates in Tumor-Only Sequencing for Cancer Treatment
-
NantHealth to Present on the Future of Device Connectivity across the Continuum of Care at HIMSS18
-
NantWorks to Present Healthcare and Biotechnology Platforms at 36th Annual J.P. Morgan Healthcare Conference on January 9, 2018 in San Francisco, CA
-
NantHealth to Support the University of California San Francisco in Research Initiative Focused on Metastatic Breast Cancer
-
NantHealth Ranked Number 304 Fastest Growing Company in North America on Deloitte’s 2017 Technology Fast 500™
-
NantHealth’s Vitality Mobile App Now Available on Apple and Android Devices
-
NantHealth and Asia Genomics Announce Global Expansion of GPS CancerTM in Southeast Asia
-
NantHealth Continues Global Expansion of GPS Cancer™ by Bringing Advanced Genomic Profiling to Patients in Mexico
-
NantHealth Announces Three-Year Contract Extension with Long-Time Client Blue Cross and Blue Shield of Nebraska
-
NantHealth Appoints Dr. Sandeep Reddy as Chief Medical Officer
-
NantHealth’s GPS Cancer™ Receives Support from the International Association of Fire Fighters in an Effort to Combat Job-Related Cancer
-
NantHealth to Present at the Cowen and Company 37th Annual Health Care Conference On March 7
-
NantHealth to Showcase New Oncology Solution Suite, Advanced Medication Adherance Solution and the Latest in Device Connectivity at HIMSS 2017 Annual Conference
-
Dr. Patrick Soon-Shiong to Deliver Keynote at HIMSS 2017 Intelligent Health™ Pavilion and Will Unveil NantDaVinci: the World's Largest Database of Analyzed Human Cancer Whole Genomes
-
Philadelphia Coalition for a Cure (PC4C) to Launch First of Its Kind Precision Medicine Study Supporting Collaborative Discovery for Brain Tumors with NantHealth's GPS Cancer Test Across Pediatric and
-
NantHealth to Present at the 35th Annual J.P. Morgan Healthcare Conference on January 9
-
NantHealth Expands Adoption of GPS CancerTM with New Florida Genomics Lab License and Successful Adoption by Florida Community Oncologists
-
NantHealth Added to Nasdaq Biotech Index
-
NantHealth, NantKwest and NantOmics Announce Availability of GPS Cancer™ and Phase I – III QUILT Trials Through the U.S. National Institutes of Health’s ClinicalTrials.gov
-
NantHealth And TransMed Systems Partner to Enable and Inform Community Oncologists of the Most Effective Tools and Technologies for Personalized Cancer Treatments Using GPS Cancer™
-
NantHealth Announces Exclusive Reseller Agreement for GPS Cancer™ with Oncotest-Teva in Israel
-
NantHealth Continues Global Expansion Of GPS Cancer™ By Bringing Advanced Molecular Profiling to Patients in the Middle East Through Partnership with Lunatus
-
NantHealth Reports 76% Increase in Total Q3 Net Revenue 2016 vs 2015, Gross Profit Triples
-
NantHealth to Report 2016 Third-Quarter Financial Results and Host Conference Call on Monday, November 7
-
NantHealth Announces Global Expansion of GPS Cancer; Partners with Sorgente to Expand Availability of GPS Cancer™ to Italy
-
Cancer MoonShot 2020 Milestone: Announcing Launch of the Nation’s Largest Pediatric Brain Tumor Atlas
-
NantHealth Expands GPS Cancer™ Coverage Through Partnership with Horizon Blue Cross Blue Shield of New Jersey and COTA
-
NantHealth Announces Immunotherapy Clinical Trials in the Mid-Atlantic, First Whole Genomics Supercomputing Medical Reasoning Engine Helps Oncologists Make Informed Treatment Decisions for Cancer Pati
-
NantHealth Partners with Children’s Hospital of Orange County to Revolutionize Pediatric Cancer Care Through the Use of GPS Cancer™
-
Phoenix Children’s Hospital Selects NantHealth’s Molecular Testing Platform and Comprehensive Suite of Software Solutions for Precision Cancer Care
-
NantHealth Reports Strong 2016 Second-Quarter Revenues and Continued Progress on GPS Cancer and NantOS Platform
-
Sanford Health Selects NantHealth's eviti Platform to Deliver Efficient, Evidence-Based Oncology Decision Support for Treatment of Cancer Patients
-
NantHealth to Report 2016 Second-Quarter Financial Results and Host Conference Call on Tuesday, August 9
-
NantHealth and University of Utah Establish Heritage 1K Project to Discover Genetic Causes of 25 Rare and Common Diseases
-
Cancer MoonShot 2020 and NantHealth Form Collaborative Melanoma and Sarcoma Working Group with Columbia University and UPMC to Accelerate Personalized Immunotherapy
-
Cancer MoonShot 2020 Announces Breast Cancer Working Group with Multiple Leading Cancer Centers and the Launch of GPS Cancer at ASCO 2016
-
NantHealth (NH) Says Genomic Proteomic Spectrometry Cancer Test Now Commercially Available
-
NantHealth Announces Commercial Availability of GPS Cancer™ and Launch of GPS Cancer Browser on a Secure Mobile Platform at the 2016 American Society of Clinical Oncology Annual Meeting

